ISG to Evaluate Life Sciences Service Providers Worldwide
Information Services Group (ISG) has launched a comprehensive research study examining service providers in the life sciences sector. The study will result in an ISG Provider Lens™ report on Life Sciences Digital Services, scheduled for release in June 2025. The research encompasses both digital service providers and contract research organizations (CROs), focusing on clinical development, patient management, and manufacturing supply chain support.
The study will evaluate providers across eight quadrants - five examining service provider capabilities and three examining CRO capabilities. Key areas include clinical development, patient engagement, manufacturing supply chain, pharmacovigilance, regulatory affairs, and commercial operations. ISG has distributed surveys to over 130 providers in the global life sciences market.
The research addresses the industry's digital transformation challenges, including the need to advance research, navigate regulatory complexities, and integrate advanced technologies like AI, ML, and automation. The study particularly focuses on how providers are helping companies deal with data quality issues and reduce time-to-market while maintaining security and compliance.
Information Services Group (ISG) ha avviato uno studio di ricerca completo che esamina i fornitori di servizi nel settore delle scienze della vita. Lo studio porterà a un rapporto ISG Provider Lens™ sui Servizi Digitali per le Scienze della Vita, previsto per il rilascio a giugno 2025. La ricerca comprende sia i fornitori di servizi digitali che le organizzazioni di ricerca a contratto (CRO), concentrandosi sullo sviluppo clinico, la gestione dei pazienti e il supporto alla catena di approvvigionamento nella produzione.
Lo studio valuterà i fornitori su otto quadranti - cinque che esaminano le capacità dei fornitori di servizi e tre che esaminano le capacità delle CRO. Le aree chiave includono lo sviluppo clinico, l'engagement dei pazienti, la catena di approvvigionamento nella produzione, la farmacovigilanza, gli affari regolatori e le operazioni commerciali. ISG ha distribuito sondaggi a oltre 130 fornitori nel mercato globale delle scienze della vita.
La ricerca affronta le sfide della trasformazione digitale del settore, inclusa la necessità di avanzare nella ricerca, affrontare le complessità normative e integrare tecnologie avanzate come AI, ML e automazione. Lo studio si concentra in particolare su come i fornitori stiano aiutando le aziende a gestire le problematiche relative alla qualità dei dati e a ridurre il time-to-market mantenendo al contempo sicurezza e conformità.
Information Services Group (ISG) ha lanzado un estudio de investigación integral que examina a los proveedores de servicios en el sector de las ciencias de la vida. El estudio resultará en un informe de ISG Provider Lens™ sobre Servicios Digitales para las Ciencias de la Vida, programado para su lanzamiento en junio de 2025. La investigación abarca tanto a proveedores de servicios digitales como a organizaciones de investigación por contrato (CRO), enfocándose en el desarrollo clínico, la gestión de pacientes y el apoyo a la cadena de suministro de fabricación.
El estudio evaluará a los proveedores en ocho cuadrantes - cinco que examinan las capacidades de los proveedores de servicios y tres que examinan las capacidades de las CRO. Las áreas clave incluyen el desarrollo clínico, el compromiso del paciente, la cadena de suministro de fabricación, la farmacovigilancia, los asuntos regulatorios y las operaciones comerciales. ISG ha distribuido encuestas a más de 130 proveedores en el mercado global de ciencias de la vida.
La investigación aborda los desafíos de la transformación digital de la industria, incluyendo la necesidad de avanzar en la investigación, navegar por las complejidades regulatorias e integrar tecnologías avanzadas como IA, ML y automatización. El estudio se centra particularmente en cómo los proveedores están ayudando a las empresas a lidiar con problemas de calidad de datos y reducir el tiempo de comercialización, manteniendo la seguridad y el cumplimiento.
정보 서비스 그룹 (ISG)는 생명 과학 분야의 서비스 제공업체를 조사하는 포괄적인 연구를 시작했습니다. 이 연구는 2025년 6월에 발표될 예정인 생명 과학 디지털 서비스에 관한 ISG 제공업체 렌즈™ 보고서로 이어질 것입니다. 연구는 디지털 서비스 제공업체와 계약 연구 기관 (CRO)을 포함하며, 임상 개발, 환자 관리 및 제조 공급망 지원에 중점을 둡니다.
이 연구는 여덟 개 사분면에서 제공업체를 평가합니다 - 다섯 개는 서비스 제공업체의 능력을 평가하고 세 개는 CRO의 능력을 평가합니다. 주요 분야에는 임상 개발, 환자 참여, 제조 공급망, 약물 감시, 규제 업무 및 상업 운영이 포함됩니다. ISG는 글로벌 생명 과학 시장의 130개 이상의 제공업체에 설문 조사를 배포했습니다.
이 연구는 연구를 발전시키고 규제 복잡성을 탐색하며 AI, ML 및 자동화와 같은 첨단 기술을 통합할 필요성을 포함하여 업계의 디지털 혁신 과제를 다룹니다. 연구는 특히 제공업체가 데이터 품질 문제를 해결하고 보안 및 규정을 유지하면서 시장 출시 시간을 단축하는 데 어떻게 도움을 주고 있는지에 중점을 둡니다.
Information Services Group (ISG) a lancé une étude de recherche complète examinant les fournisseurs de services dans le secteur des sciences de la vie. L'étude aboutira à un rapport ISG Provider Lens™ sur les Services Numériques pour les Sciences de la Vie, prévu pour juin 2025. La recherche englobe à la fois des fournisseurs de services numériques et des organisations de recherche contractuelles (CRO), en se concentrant sur le développement clinique, la gestion des patients et le soutien à la chaîne d'approvisionnement en fabrication.
L'étude évaluera les fournisseurs dans huit quadrants - cinq examinant les capacités des fournisseurs de services et trois examinant les capacités des CRO. Les domaines clés incluent le développement clinique, l'engagement des patients, la chaîne d'approvisionnement en fabrication, la pharmacovigilance, les affaires réglementaires et les opérations commerciales. ISG a distribué des enquêtes à plus de 130 fournisseurs sur le marché mondial des sciences de la vie.
La recherche aborde les défis de la transformation numérique de l'industrie, y compris la nécessité de faire avancer la recherche, de naviguer dans les complexités réglementaires et d'intégrer des technologies avancées telles que l'IA, le ML et l'automatisation. L'étude se concentre particulièrement sur la manière dont les fournisseurs aident les entreprises à gérer les problèmes de qualité des données et à réduire le délai de mise sur le marché tout en maintenant la sécurité et la conformité.
Information Services Group (ISG) hat eine umfassende Forschungsstudie gestartet, die Dienstleister im Bereich der Lebenswissenschaften untersucht. Die Studie wird zu einem ISG Provider Lens™-Bericht über Digitale Dienstleistungen in den Lebenswissenschaften führen, der für Juni 2025 geplant ist. Die Forschung umfasst sowohl digitale Dienstleister als auch Vertragsforschungsorganisationen (CROs) und konzentriert sich auf klinische Entwicklung, Patientenmanagement und Unterstützung der Lieferkette in der Produktion.
Die Studie bewertet Anbieter in acht Quadranten - fünf, die die Fähigkeiten von Dienstleistern untersuchen, und drei, die die Fähigkeiten von CROs untersuchen. Wichtige Bereiche sind klinische Entwicklung, Patientenengagement, Lieferkette in der Produktion, Pharmakovigilanz, regulatorische Angelegenheiten und kommerzielle Operationen. ISG hat Umfragen an über 130 Anbieter im globalen Lebenswissenschaftsmarkt verteilt.
Die Forschung befasst sich mit den Herausforderungen der digitalen Transformation der Branche, einschließlich der Notwendigkeit, die Forschung voranzutreiben, regulatorische Komplexitäten zu navigieren und fortschrittliche Technologien wie KI, ML und Automatisierung zu integrieren. Die Studie konzentriert sich insbesondere darauf, wie Anbieter Unternehmen helfen, Probleme mit der Datenqualität zu bewältigen und die Markteinführungszeit zu verkürzen, während sie Sicherheit und Compliance aufrechterhalten.
- Comprehensive market analysis covering 8 distinct service areas
- Large survey scope with over 130 providers being evaluated
- Integration of customer experience (CX) data in the evaluation
- None.
Upcoming ISG Provider Lens™ report will assess the capabilities of providers helping companies advance their research and navigate regulatory complexities
The study results will be published in a comprehensive ISG Provider Lens™ report, called Life Sciences Digital Services, scheduled to be released in June 2025. The report will cover both digital service providers and contract research organizations (CROs) offering support for clinical development, patient management and the manufacturing supply chain.
Enterprise buyers will be able to use information from the report to evaluate their current vendor relationships, potential new engagements and available offerings, while ISG advisors use the information to recommend providers to the firm’s buy-side clients.
The life sciences industry is undergoing significant digital transformation driven by the urgent need to advance research and navigate regulatory complexities. Advanced technologies such as AI, ML and automation are playing a prominent role, yet issues with low-quality, outdated and incomplete data challenge seamless process integration.
The imperative to reduce time-to-market continues to prompt increased collaboration among industry players, but traditional data management tools often result in data duplication and raise security concerns.
“Leaders in life sciences are faced with navigating a fluctuating landscape where the costs of innovation have surged, often exponentially,” said Iain Fisher, director, ISG Provider Lens Research. “However, there is a growing need for these companies to adopt innovation at scale, especially to maximize the efficiency of business models newly empowered by AI.”
ISG has distributed surveys to more than 130 providers serving the global life sciences and services market. Working in collaboration with ISG’s global advisors, the research team will produce eight quadrants – five of which examine the capabilities of service providers, and three of which examine the capabilities of CROs, based on ISG’s experience working with its clients. The five service provider-related quadrants are:
- Clinical Development, evaluating providers of technology for patient recruitment, data collection, monitoring, analysis and regulatory compliance. Providers integrate innovations such as AI, big data analytics, mobile health applications and electronic health records to aid in patient identification and safety monitoring, improve treatment efficacy and ensure compliance with regulations and reporting requirements.
- Patient Engagement, assessing providers specializing in life science customer services, utilizing digital tools such as mobile applications, wearable devices, telehealth platforms and online portals to facilitate seamless communication between patients and healthcare providers. Digitally transformed patient engagement fosters a collaborative, patient-centric healthcare ecosystem that improve healthcare outcomes.
- Manufacturing Supply Chain, covering providers adopting digital technologies such as IoT, AI, blockchain and advanced analytics to enhance efficiency, visibility and agility across the entire supply chain. Advancements in supply chain management streamline operations, reduce lead times, minimize errors and ensure regulatory compliance, while cultivating a more resilient, adaptive and responsive ecosystem.
- Pharmacovigilance and Regulatory Affairs — Digital Evolution, evaluating providers supporting patient safety monitoring, adhering to regulatory requirements and facilitating reporting through diverse processes and platforms leveraging AI, natural language processing and machine learning. Recent breakthroughs in these fields are opening avenues for innovation and improved operational efficiency.
- Commercial Operations — Digital Evolution, assessing providers driving the digital evolution of life sciences commercial operations, including data analytics, customer engagement, supply chain optimization and personalized medicine, through technologies such as AI and IoT. More life sciences companies are seeking digital channels for direct-to-consumer engagement, online sales and efficient product distribution.
The three CRO-related quadrants are:
- Clinical Development, covering CROs that support life sciences in the execution of clinical trials across all phases. High costs, along with complex issues such as high failure rates and the need to maintain efficient service delivery levels, make CROs critical for helping organizations mitigate operational and financial risks, optimizing patient safety monitoring and ensuring adherence to global standards.
- Patient Engagement, evaluating CROs that focus on design strategies that emphasize personalize outreach, education and support to improve recruitment efficiency and clinical trial experiences. These CROs leverage digital platforms, AI-driven insights and behavioral analytics for proactive engagement while ensuring compliance with privacy regulations.
- Pharmacovigilance and Regulatory Affairs — Digital Evolution, assessing CROs that help companies ensure drug safety while navigating adverse event reporting and regulatory frameworks. Services in this space also encompass benefit/risk assessment, submission preparation and communication with regulatory authorities for compliance and transparency.
The study will cover the global life sciences and digital services market and examine products and services available worldwide. ISG analyst Rohan Sinha will serve as lead author of the report.
A list of identified providers and vendors and further details on the study are available in this digital brochure. Companies not listed as life sciences digital service providers can contact ISG and ask to be included in the study.
All 2025 ISG Provider Lens™ evaluations feature expanded customer experience (CX) data that measures actual enterprise experience with specific provider services and solutions, based on ISG’s continuous CX research. Enterprise customers wishing to share their experience about a specific provider or vendor are invited to complete this online survey. Participants will receive a copy of this report in return for their feedback.
About ISG Provider Lens™ Research
The ISG Provider Lens™ Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across
About ISG
ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250221711261/en/
Will Thoretz, ISG
+1 203 517 3119
will.thoretz@isg-one.com
Julianna Sheridan, Matter Communications for ISG
+1 978-518-4520
isg@matternow.com
Source: Information Services Group, Inc.
FAQ
When will ISG release its Life Sciences Digital Services report (III)?
How many service providers is ISG (III) evaluating for the Life Sciences report?
What are the main quadrants covered in ISG's 2025 Life Sciences evaluation?
What technological challenges is ISG (III) addressing in the life sciences sector?
